Cash and cash equivalents (USD, thousands)

Accounts receivable, net (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Total current assets (USD, thousands)

Operating lease right-of-use assets, net (USD, thousands)

Property and equipment, net (USD, thousands)

Other long-term assets (USD, thousands)

Goodwill (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued liabilities (USD, thousands)

Current portion of operating lease liabilities (USD, thousands)

Other current liability (USD, thousands)

Deferred revenue (USD, thousands)

Total current liabilities (USD, thousands)

Non-current operating lease liabilities (USD, thousands)

Other non-current liabilities (USD, thousands)

Total liabilities (USD, thousands)

Common stock, $ .001 par value; 200,000,000 shares authorized (USD, thousands)

Treasury stock, at cost (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated deficit (USD, thousands)

Total stockholders’ equity (deficiency) (USD, thousands)

Total liabilities and stockholders’ equity (deficiency) (USD, thousands)

1009452f437449c8eb33e855aa603d63978bb489581c1acb18cb855ddd0df136

Oncology Revenue (USD, thousands)

Cost of Oncology Revenue (USD, thousands)

Research and Development (USD, thousands)

Sales and Marketing (USD, thousands)

General and Administrative (USD, thousands)

Loss on Disposal of Equipment (USD, thousands)

Asset Impairment (USD, thousands)

Total Costs and Operating Expenses (USD, thousands)

Income (Loss) from Operations (USD, thousands)

Other Income (Expense) (USD, thousands)

Income (Loss) before Provision for Income Taxes (USD, thousands)

Provision for Income Taxes (USD, thousands)

Net Income (Loss) (USD, thousands)

Net Income (Loss) per Common Share - Basic (USD per share)

Net Income (Loss) per Common Share - Diluted (USD per share)

Weighted Average Common Shares Outstanding - Basic (shares)

Weighted Average Common Shares Outstanding - Diluted (shares)

0ef1727161b69f2686a71e89089632587aa1400ee29b214dfab8d26c2f1e2ea7

Net income (loss) [USD, thousands]

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Stock-based compensation [USD, thousands]

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation and amortization expense [USD, thousands]

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Loss on disposal of equipment [USD, thousands]

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Operating lease right-of use assets [USD, thousands]

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Allowance for doubtful accounts and estimated credit losses [USD, thousands]

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Asset impairment [USD, thousands]

Changes in operating assets and liabilities: Accounts receivable [USD, thousands]

Changes in operating assets and liabilities: Prepaid expenses and other current assets [USD, thousands]

Changes in operating assets and liabilities: Other long term assets [USD, thousands]

Changes in operating assets and liabilities: Accounts payable [USD, thousands]

Changes in operating assets and liabilities: Accrued liabilities [USD, thousands]

Changes in operating assets and liabilities: Operating lease liabilities [USD, thousands]

Changes in operating assets and liabilities: Deferred revenue [USD, thousands]

Net cash provided by (used in) operating activities [USD, thousands]

Investing activities: Purchase of property and equipment [USD, thousands]

Net cash used in investing activities [USD, thousands]

Financing activities: Proceeds from exercise of options [USD, thousands]

Financing activities: Finance lease payments [USD, thousands]

Financing activities: Repurchases of common stock [USD, thousands]

Net cash provided by (used in) financing activities [USD, thousands]

Increase (decrease) in cash [USD, thousands]

Non-cash activities: Equipment purchased in accounts payable [USD, thousands]

Non-cash activities: Purchased equipment under finance lease [USD, thousands]

Non-cash activities: Right-of-use assets obtained in exchange for operating lease liabilities [USD, thousands]

Cash at beginning of period [USD, thousands]

Cash at end of period [USD, thousands]

e49d5a7e707ab26998573d410264f937090acd8ddc94b297ecbe58a0c8e646b6

Oncology Services

Pharmacology Services

Other TOS Revenue

Total Revenue

7e158265520886e1fa39a50b57ad39e86ca97ec418b5adb12240c83a34ab9b17

- Other TOS Revenue

- TOS License Revenue

Personalized Oncology Services

c4cfe90254d6f1e56870ac6c7faa0ee18c8f30fd12fe214c75c8d0d3c158e4b8

CHAMPIONS ONCOLOGY (CSBR)

Financials